Artelo Biosciences Inc. (ARTL) at a glance

Artelo Biosciences Inc. (ARTL) is a micro-cap Healthcare company. It trades at $1.14, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 45/100 overall. Its strongest dimension is Value (58/100) and its weakest is Momentum (12/100).

Price
$1.14
Market cap
$4.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.12 to $85.80
Vestovix Score45/ 100How this works
Value
58
Growth
50
Income
40
Safety
46
Momentum
12

Other Healthcare stocks

See all